Hyung Sun Kim

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Joon Seong Park · 13 shared papers, 2017–2024 · strength 2.08
   • Paper Neural Wiskott-Aldrich syndrome protein (N-WASP) promotes distant metastasis in pancreatic ductal adenocarcinoma via ac… DOI 10.32604/or.2024.044029↗
   • Paper Novel Predictive Strategy Using CA19-9 and Fecal Elastase Levels to Make Treatment Decisions for Resectable Pancreatic … DOI 10.3390/biomedicines13010062↗
   • Paper Intraoperative Radiotherapy for Resectable Pancreatic Cancer Using a Low-Energy X-Ray Source: Postoperative Complicatio… DOI 10.3349/ymj.2022.63.5.405↗
2. Hyeon Woong Kang · 5 shared papers, 2022–2024 · strength 0.89
   • Paper Neural Wiskott-Aldrich syndrome protein (N-WASP) promotes distant metastasis in pancreatic ductal adenocarcinoma via ac… DOI 10.32604/or.2024.044029↗
   • Paper SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer. DOI 10.3390/cells12202509↗
   • Paper The role of LOXL2 induced by glucose metabolism-activated NF-κB in maintaining drug resistance through EMT and cancer s… DOI 10.1007/s00109-023-02369-6↗
3. Myeong‐Jin Kim · 4 shared papers, 2022–2023 · strength 0.66
   • Paper SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer. DOI 10.3390/cells12202509↗
   • Paper The role of LOXL2 induced by glucose metabolism-activated NF-κB in maintaining drug resistance through EMT and cancer s… DOI 10.1007/s00109-023-02369-6↗
   • Paper Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc … DOI 10.1080/15384047.2023.2272334↗
4. Da Eun Lee · 3 shared papers, 2022–2024 · strength 0.54
   • Paper Neural Wiskott-Aldrich syndrome protein (N-WASP) promotes distant metastasis in pancreatic ductal adenocarcinoma via ac… DOI 10.32604/or.2024.044029↗
   • Paper The role of LOXL2 induced by glucose metabolism-activated NF-κB in maintaining drug resistance through EMT and cancer s… DOI 10.1007/s00109-023-02369-6↗
   • Paper Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunc… DOI 10.3389/fphar.2022.934746↗
5. Dong Sup Yoon · 4 shared papers, 2017–2021 · strength 0.52
   • Paper Radical antegrade modular pancreatosplenectomy (RAMPS) versus conventional distal pancreatectomy for left-sided pancrea… DOI 10.1007/s00595-021-02280-y↗
   • Paper Is Neoadjuvant Treatment Justified in Clinical T1 Pancreatic Ductal Adenocarcinoma? DOI 10.3390/jcm10040873↗
   • Paper Specific protein 1(SP1) regulates the epithelial-mesenchymal transition via lysyl oxidase-like 2(LOXL2) in pancreatic d… DOI 10.1038/s41598-019-42501-6↗
6. Woosol Chris Hong · 3 shared papers, 2022–2023 · strength 0.49
   • Paper SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer. DOI 10.3390/cells12202509↗
   • Paper The role of LOXL2 induced by glucose metabolism-activated NF-κB in maintaining drug resistance through EMT and cancer s… DOI 10.1007/s00109-023-02369-6↗
   • Paper Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunc… DOI 10.3389/fphar.2022.934746↗
7. Yun Sun Lee · 3 shared papers, 2019–2023 · strength 0.45
   • Paper The role of LOXL2 induced by glucose metabolism-activated NF-κB in maintaining drug resistance through EMT and cancer s… DOI 10.1007/s00109-023-02369-6↗
   • Paper Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc … DOI 10.1080/15384047.2023.2272334↗
   • Paper Specific protein 1(SP1) regulates the epithelial-mesenchymal transition via lysyl oxidase-like 2(LOXL2) in pancreatic d… DOI 10.1038/s41598-019-42501-6↗
8. Ik Jae Lee · 2 shared papers, 2019–2022 · strength 0.32
   • Paper Intraoperative Radiotherapy for Resectable Pancreatic Cancer Using a Low-Energy X-Ray Source: Postoperative Complicatio… DOI 10.3349/ymj.2022.63.5.405↗
   • Paper A phase II study of intraoperative radiotherapy using a low-energy x-ray source for resectable pancreatic cancer: a stu… DOI 10.1186/s12893-019-0492-x↗
9. Yeona Cho · 2 shared papers, 2019–2022 · strength 0.32
   • Paper Intraoperative Radiotherapy for Resectable Pancreatic Cancer Using a Low-Energy X-Ray Source: Postoperative Complicatio… DOI 10.3349/ymj.2022.63.5.405↗
   • Paper A phase II study of intraoperative radiotherapy using a low-energy x-ray source for resectable pancreatic cancer: a stu… DOI 10.1186/s12893-019-0492-x↗
10. Jun Won Kim · 2 shared papers, 2019–2022 · strength 0.32
    • Paper Intraoperative Radiotherapy for Resectable Pancreatic Cancer Using a Low-Energy X-Ray Source: Postoperative Complicatio… DOI 10.3349/ymj.2022.63.5.405↗
    • Paper A phase II study of intraoperative radiotherapy using a low-energy x-ray source for resectable pancreatic cancer: a stu… DOI 10.1186/s12893-019-0492-x↗
11. Jin Hong Lim · 2 shared papers, 2017–2025 · strength 0.31
    • Paper A New Staining Method Using Methionyl-tRNA Synthetase 1 Antibody for Endoscopic Ultrasound-Guided Fine-Needle Aspiratio… DOI 10.3390/diagnostics15141783↗
    • Paper Surgical management of malignant bowel obstruction in recurrent pancreatic cancer. DOI 10.1016/j.ijscr.2017.01.021↗
12. Jung Hyun Jo · 1 shared paper, 2025 · strength 0.22
    • Paper A New Staining Method Using Methionyl-tRNA Synthetase 1 Antibody for Endoscopic Ultrasound-Guided Fine-Needle Aspiratio… DOI 10.3390/diagnostics15141783↗
13. Jae Hee Cho · 1 shared paper, 2025 · strength 0.22
    • Paper A New Staining Method Using Methionyl-tRNA Synthetase 1 Antibody for Endoscopic Ultrasound-Guided Fine-Needle Aspiratio… DOI 10.3390/diagnostics15141783↗
14. Sung Ill Jang · 1 shared paper, 2025 · strength 0.22
    • Paper A New Staining Method Using Methionyl-tRNA Synthetase 1 Antibody for Endoscopic Ultrasound-Guided Fine-Needle Aspiratio… DOI 10.3390/diagnostics15141783↗
15. Dong Ki Lee · 1 shared paper, 2025 · strength 0.22
    • Paper A New Staining Method Using Methionyl-tRNA Synthetase 1 Antibody for Endoscopic Ultrasound-Guided Fine-Needle Aspiratio… DOI 10.3390/diagnostics15141783↗
16. Hye‐Sol Jung · 1 shared paper, 2024 · strength 0.22
    • Paper Novel Predictive Strategy Using CA19-9 and Fecal Elastase Levels to Make Treatment Decisions for Resectable Pancreatic … DOI 10.3390/biomedicines13010062↗
17. Mirang Lee · 1 shared paper, 2024 · strength 0.22
    • Paper Novel Predictive Strategy Using CA19-9 and Fecal Elastase Levels to Make Treatment Decisions for Resectable Pancreatic … DOI 10.3390/biomedicines13010062↗
18. Won‐Gun Yun · 1 shared paper, 2024 · strength 0.22
    • Paper Novel Predictive Strategy Using CA19-9 and Fecal Elastase Levels to Make Treatment Decisions for Resectable Pancreatic … DOI 10.3390/biomedicines13010062↗
19. Jin‐Young Jang · 1 shared paper, 2024 · strength 0.22
    • Paper Novel Predictive Strategy Using CA19-9 and Fecal Elastase Levels to Make Treatment Decisions for Resectable Pancreatic … DOI 10.3390/biomedicines13010062↗
20. Wooil Kwon · 1 shared paper, 2024 · strength 0.22
    • Paper Novel Predictive Strategy Using CA19-9 and Fecal Elastase Levels to Make Treatment Decisions for Resectable Pancreatic … DOI 10.3390/biomedicines13010062↗
21. Tae Ho Hong · 1 shared paper, 2021 · strength 0.17
    • Paper Radical antegrade modular pancreatosplenectomy (RAMPS) versus conventional distal pancreatectomy for left-sided pancrea… DOI 10.1007/s00595-021-02280-y↗
22. Jongman Yoo · 1 shared paper, 2023 · strength 0.17
    • Paper Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc … DOI 10.1080/15384047.2023.2272334↗
23. Kota Nakamura · 1 shared paper, 2021 · strength 0.14
    • Paper Is Neoadjuvant Treatment Justified in Clinical T1 Pancreatic Ductal Adenocarcinoma? DOI 10.3390/jcm10040873↗
24. Kenji Nakagawa · 1 shared paper, 2021 · strength 0.14
    • Paper Is Neoadjuvant Treatment Justified in Clinical T1 Pancreatic Ductal Adenocarcinoma? DOI 10.3390/jcm10040873↗
25. Masayuki Sho · 1 shared paper, 2021 · strength 0.14
    • Paper Is Neoadjuvant Treatment Justified in Clinical T1 Pancreatic Ductal Adenocarcinoma? DOI 10.3390/jcm10040873↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.